H
HoyleCohen’s Summit Therapeutics SMMT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $674K | Buy |
86,408
+2,000
| +2% | +$15.6K | 0.05% | 164 |
|
2024
Q1 | $349K | Buy |
84,408
+10,000
| +13% | +$41.4K | 0.03% | 223 |
|
2023
Q4 | $194K | Hold |
74,408
| – | – | 0.02% | 262 |
|
2023
Q3 | $139K | Hold |
74,408
| – | – | 0.01% | 252 |
|
2023
Q2 | $187K | Hold |
74,408
| – | – | 0.02% | 253 |
|
2023
Q1 | $130K | Buy |
74,408
+43,976
| +145% | +$77K | 0.01% | 253 |
|
2022
Q4 | $129K | Hold |
30,432
| – | – | 0.01% | 258 |
|
2022
Q3 | $36K | Hold |
30,432
| – | – | ﹤0.01% | 254 |
|
2022
Q2 | $30K | Buy |
30,432
+15,000
| +97% | +$14.8K | ﹤0.01% | 256 |
|
2022
Q1 | $38K | Hold |
15,432
| – | – | ﹤0.01% | 270 |
|
2021
Q4 | $42K | Hold |
15,432
| – | – | ﹤0.01% | 273 |
|
2021
Q3 | $77K | Buy |
15,432
+5,000
| +48% | +$24.9K | 0.01% | 264 |
|
2021
Q2 | $78 | Buy |
10,432
+73
| +0.7% | +$1 | 0.01% | 265 |
|
2021
Q1 | $61K | Hold |
10,359
| – | – | 0.01% | 266 |
|
2020
Q4 | $49K | Buy |
+10,359
| New | +$49K | 0.01% | 223 |
|